Identifying a Specific Biomarker Allows for Improved Quality of Life

Serositis and intermittent fever with cyclic white cell count elevations above normal range pose diagnostic challenges. Identifying specific biomarkers may allow for earlier treatment and improved quality of life for those diseases that share common symptoms and fall ambiguously in the domain of the rheumatologist, the infectious disease specialist or the hematologist. As our approach to diagnostics is growing increasingly sophisticated and moleculartools are becoming more commonplace, genotype-phenotype correlations should become immediately clinically useful.